Discover 3,064 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,064
Testing Atezolizumab With Selinexor in People ≥ 12 Years Old With Alveolar Soft Part Sarcoma, AXIOM Trial
for
Advanced Alveolar Soft Part Sarcoma,
Location: Hartford CT, New Haven CT, Trumbull CT, Bethesda MD,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 12+
Code: NCT05333458
Phase2, Recruiting
Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients
for
Psoriatic Arthritis
Location: Worcester MA, New York NY, Philadelphia PA,
Sponsor: University of Pennsylvania
Sex: All
Age: 18 - 70+
Code: NCT05669833
Phase3, Recruiting
VEPTR Implantation to Treat Children With Early Onset Scoliosis Without Rib Abnormalities
for
Congenital Progressive Scoliosis, Infantile
Location: Philadelphia PA, Salt Lake City UT
Sponsor: Shriners Hospitals for Children
Sex: All
Age: 1 - 10
Code: NCT00689533
Recruiting
Elucidating TAAR-1, Dopamine, and Norepinephrine in Binge Eating Disorder Using Solriamfetol
for
Binge-Eating Disorder
Location: Boston MA, Cromwell CT, Mount Kisco NY, New York NY,
Get alerts for new trials in your area by subscribing now
A Study to Investigate the Efficacy and Safety of Sonrotoclax Plus Zanubrutinib Compared With Placebo Plus Zanubrutinib in Adults With Relapsed/Refractory Mantle Cell Lymphoma (CELESTIAL-RRMCL)
for
Mantle Cell Lymphoma, B Cell Lymphoma
Location: Boston MA, New Haven CT, New York NY, Paramus NJ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06742996
Phase3, Recruiting
Follow-up Visit of High Risk Infants
for
Infant, Newborn, Infant, Low Birth Weight,
Location: Philadelphia PA, Durham NC, Cleveland OH, Detroit MI,
Sponsor: NICHD Neonatal Research Network
Sex: All
Age: 1 - 2
Code: NCT00009633
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)
for
Triple Negative Breast Cancer
Location: Scarborough ME, South Weymouth MA, Boston MA,
Sponsor: Gilead Sciences
Sex: All
Age: 18+
Code: NCT05633654
Phase3, Recruiting
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)